Identification of the MEK1(F129L) Activating Mutation as a Potential Mechanism of Acquired Resistance to MEK Inhibition in Human Cancers Carrying the B-Raf V600E Mutation
Year: 2011
Type: article
Source: Cancer Research
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: Chugai Pharmaceutical
OpenAlex ID: W2157144029
